|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_IssueDocumentAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|http://www.xbrl.org/2003/role/terseLabel
|
|
-
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
The issue document approved by the Capital Markets Board for shares with a nominal value of TRY 7,802,851 to be issued within the scope of the conditional increase of our company's issued capital from TRY 2,255,830,245 to TRY 2,263,633,096 is attached.
Within the scope of the conditional capital increase to be realized, the preeemptive rights will be completely restricted and all of the new shares to be issued will be allocated to the Convertible Bonds holders who wish to exercise their conversion rights in October 2022.
In the event of any discrepancy between the Turkish and English versions of this disclosure statement, the original Turkish version shall prevail. SASA disclaims all warranties and makes no representations about the accuracy or completeness of the English translation and assumes no liability for any errors, omissions or inaccuracies that may arise from use of this translation.
|
||||||||